|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
208,785,000 |
Market
Cap: |
45.06(B) |
Last
Volume: |
1,348,221 |
Avg
Vol: |
0 |
52
Week Range: |
$177.16 - $259.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 785 |
Guru Rank Value : 1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile IQVIA Holdings is a provider of analytics, technology solutions, and clinical research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to its life science clients; Research and Development Solutions, which primarily serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services; and Contract Sales and Medical Solutions, which provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the healthcare market.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
68,853 |
109,287 |
120,554 |
Total Sell Value |
$0 |
$17,072,068 |
$25,579,880 |
$27,988,147 |
Total People Sold |
0 |
4 |
5 |
5 |
Total Sell Transactions |
0 |
5 |
7 |
11 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gillings Mireille |
Director |
|
2015-02-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
13,468 |
13,167,052 |
|
- |
|
Gfef Limited Partnership |
Executive Chairman |
|
2015-02-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
13,468 |
161,699 |
|
- |
|
Gillings Mireille |
Director |
|
2015-02-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
13,468 |
13,167,052 |
|
- |
|
Gfef Limited Partnership |
Executive Chairman |
|
2015-02-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
13,468 |
161,699 |
|
- |
|
Gfef Limited Partnership |
Executive Chairman |
|
2015-02-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,468 |
13,005,353 |
|
- |
|
Gordon Kevin K |
Exec VP and CFO |
|
2015-02-02 |
4 |
AS |
$60.19 |
$1,504,750 |
D/D |
(25,000) |
17,899 |
|
- |
|
Gordon Kevin K |
Exec VP and CFO |
|
2015-02-02 |
4 |
OE |
$17.53 |
$438,250 |
D/D |
25,000 |
42,899 |
|
- |
|
Evanisko Michael J |
Director |
|
2015-01-07 |
4 |
AS |
$57.86 |
$144,650 |
D/D |
(2,500) |
6,300 |
|
- |
|
Gordon Kevin K |
Exec VP and CFO |
|
2015-01-02 |
4 |
AS |
$59.16 |
$1,479,000 |
D/D |
(25,000) |
17,899 |
|
- |
|
Gordon Kevin K |
Exec VP and CFO |
|
2015-01-02 |
4 |
OE |
$17.53 |
$438,250 |
D/D |
25,000 |
42,899 |
|
- |
|
Gillings Dennis B Ph D |
Executive Chairman |
|
2014-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
81,668 |
13,018,821 |
|
- |
|
Gillings Mireille |
Director |
|
2014-12-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
81,668 |
13,167,052 |
|
- |
|
Greenberg Jack M |
Director |
|
2014-12-11 |
4 |
AS |
$57.41 |
$378,906 |
D/D |
(6,600) |
900 |
|
- |
|
Greenberg Jack M |
Director |
|
2014-12-11 |
4 |
OE |
$21.20 |
$139,920 |
D/D |
6,600 |
7,500 |
|
- |
|
Greenberg Jack M |
Director |
|
2014-12-11 |
4 |
AS |
$57.25 |
$967,983 |
I/I |
(16,908) |
10,173 |
|
- |
|
Greenberg Jack M |
Director |
|
2014-12-11 |
4 |
OE |
$15.88 |
$268,499 |
I/I |
16,908 |
27,081 |
|
- |
|
Gordon Kevin K |
Exec VP and CFO |
|
2014-12-01 |
4 |
AS |
$56.55 |
$1,419,350 |
D/D |
(25,000) |
17,899 |
|
- |
|
Gordon Kevin K |
Exec VP and CFO |
|
2014-12-01 |
4 |
OE |
$17.53 |
$438,250 |
D/D |
25,000 |
42,899 |
|
- |
|
3i U.s. Growth Corp |
10% Owner |
|
2014-11-10 |
4 |
S |
$58.09 |
$143,087,462 |
I/I |
(2,463,203) |
9,758,385 |
|
- |
|
Bain Capital Integral Investors 2008, L.p. |
10% Owner |
|
2014-11-10 |
4 |
S |
$58.09 |
$219,225,038 |
I/I |
(3,773,886) |
15,629,782 |
|
- |
|
Gordon Christopher R |
Director |
|
2014-11-10 |
4 |
S |
$58.09 |
$219,225,038 |
I/I |
(3,773,886) |
15,629,782 |
|
- |
|
Coulter James G |
May be deemed 10% Owner (3)(4) |
|
2014-11-10 |
4 |
S |
$58.09 |
$164,337,598 |
I/I |
(2,829,017) |
11,207,612 |
|
- |
|
Connaughton John |
Director |
|
2014-11-10 |
4 |
S |
$58.09 |
$219,225,038 |
I/I |
(3,773,886) |
15,629,782 |
|
- |
|
Gillings Dennis B Ph D |
Executive Chairman |
|
2014-11-10 |
4 |
S |
$58.09 |
$20,729,358 |
I/I |
(356,849) |
0 |
|
- |
|
Gillings Dennis B Ph D |
Executive Chairman |
|
2014-11-10 |
4 |
S |
$58.09 |
$186,430,444 |
D/D |
(3,209,338) |
13,100,489 |
|
- |
|
565 Records found
|
|
Page 19 of 23 |
|
|